| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |